500 Boylston Street, Boston, MA 02116 617-419-4700
Return to Results
This is an observational study to assess the long-term safety of Protopic® Ointment for the
treatment of atopic dermatitis. Patients whose ages are/were < 16 years at the time of
first tacrolimus ointment exposure are eligible to participate. No drug is distributed
during this observational trial.
Ages:0 - 16
Inclusion Criteria: - Subjects who first used Protopic® 0.03% or 0.1% before they were sixteen years of age and were treated for at least 6 weeks for the treatment of Atopic dermatitis may enroll into the study.
Sponsor: Astellas Pharma Inc
Trial ID: NCT00475605
Not Accepting Healthy Volunteers